In this episode, Brendan is joined by Tom Otis, a researcher and academic in the field of neurodegenerative diseases, discusses the latest advancements in understanding and treating conditions such as spinocerebellar ataxia (SCA) and amyotrophic lateral sclerosis (ALS). He explains the genetic basis of these diseases and the potential of CRISPR technology in developing targeted therapies. Tom emphasizes the importance of interdisciplinary collaboration and patient advocacy in driving progress in the field. He also highlights the role of physical activity in maintaining overall health and its potential impact on neurological diseases. Overall, Tom's work aims to improve the lives of individuals affected by these conditions and bring about transformative therapies.

To learn more about Tom's work and his current endeavors as the Chief S ...